Article
Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.
Oncology reports - 1 Apr 2013
Morita Hiroshi, Murata Taku, Shimizu Kasumi, Okumura Kenya, Inui Madoka, Tagawa Toshiro
Abstract excerpt
The prognosis for malignant melanoma is poor; therefore, new diagnostic methods and treatment strategies are urgently needed. Phosphodiesterase 2 (PDE2) is one of 21 phosphodiesterases, which are divided into 11 families (PDE1-PDE11). PDE2 hydrolyzes cyclic AMP (cAMP) and cyclic GMP (cGMP), and its binding to cGMP enhances the hydrolysis of cAMP. We previously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
